Aleksandra Galetin
- Pharmacology top 0.01%
- Oncology top 0.5%
- Pediatrics, Perinatology and Child Health top 0.5%
- Molecular Biology top 10%
- Computational Theory and Mathematics top 0.5%
- Co-authors
- J. Brian HoustonMichael GertzAmin Rostami‐HodjeganLeon AaronsJohn O. MinersPeter I. MackenzieDaniel ScotcherPeter Kilford
- Topics
- Drug Transport and Resistance Mechanisms (86 papers)Pharmacogenetics and Drug Metabolism (83 papers)Pharmacological Effects and Toxicity Studies (37 papers)
- Journals
- Journal of Pharmacology and Experimental TherapeuticsArchives of Biochemistry and BiophysicsMolecular Pharmacology
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Aleksandra Galetin
135 papers receiving 6.9k citations
Peers
Comparison fields: 5 of 132
- Pharmacology 4.1k
- Oncology 3.9k
- Pediatrics, Perinatology and Child Health 1.9k
- Molecular Biology 1.3k
- Computational Theory and Mathematics 713
Countries citing papers authored by Aleksandra Galetin
This map shows the geographic impact of Aleksandra Galetin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandra Galetin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandra Galetin more than expected).
Fields of papers citing papers by Aleksandra Galetin
This network shows the impact of papers produced by Aleksandra Galetin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandra Galetin. The network helps show where Aleksandra Galetin may publish in the future.
Co-authorship network of co-authors of Aleksandra Galetin
This figure shows the co-authorship network connecting the top 25 collaborators of Aleksandra Galetin. A scholar is included among the top collaborators of Aleksandra Galetin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksandra Galetin. Aleksandra Galetin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 7 | |
| 10 | 14 | |
| 11 | 24 | |
| 12 | 23 | |
| 13 | 18 | |
| 14 | 39 | |
| 15 | 22 | |
| 16 | 161 | |
| 17 | 15 | |
| 18 | 28 | |
| 19 | Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model. doi:10.1124/jpet.111.187112 | 3 |
| 20 | Time-dependent inhibition of CYP3A4 by mibefradil in recombinant CYP3A4 and human liver microsomes and impact on in vivo predictions. | 1 |
About Aleksandra Galetin
Aleksandra Galetin is a scholar working on Pharmacology, Oncology and Transplantation, having authored 138 papers that have together received 7.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (86 papers), Pharmacogenetics and Drug Metabolism (83 papers) and Pharmacological Effects and Toxicity Studies (37 papers). The work is most often cited by research in Pharmacology (4.1k citations), Oncology (3.9k citations) and Pediatrics, Perinatology and Child Health (1.9k citations). Aleksandra Galetin has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include J. Brian Houston, J. Brian Houston, Michael Gertz, Amin Rostami‐Hodjegan, Leon Aarons, John O. Miners, Peter I. Mackenzie, Daniel Scotcher, Peter Kilford and David Hallifax. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Archives of Biochemistry and Biophysics and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.